We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-14.38%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.42B
AUM Growth
-$452M
Cap. Flow
-$52.5M
Cap. Flow %
-3.71%
Top 10 Hldgs %
29.79%
Holding
375
New
15
Increased
44
Reduced
27
Closed
103

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$46.6M
2
GM icon
General Motors
GM
+$45.2M
3
OXY.WS icon
Occidental Petroleum Corp Warrants
OXY.WS
+$33.8M
4
LEN icon
Lennar Class A
LEN
+$18.2M
5
VCSA
Vacasa, Inc. Class A Common Stock
VCSA
+$16M

Top Sells

Rank Stock Value
1
HLF icon
Herbalife
HLF
+$43.7M
2
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$20.7M
3
HES
Hess
HES
+$13.6M
4
USO icon
United States Oil Fund
USO
+$8.66M
5
GROV icon
Grove Collaborative
GROV
+$8.35M

Sector Composition

Rank Sector Weight
1 Financials 33.53%
2 Healthcare 22.61%
3 Consumer Discretionary 10.28%
4 Industrials 7.33%
5 Communication Services 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QFTA
51
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$9.34M 0.66%
950,000
– –
MRNS
52
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$9.2M 0.65%
1,900,000
-32,829
-2% -$200K
GIAC
53
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
$8.87M 0.63%
900,000
– –
TRTN
54
DELISTED
Triton International Limited
TRTN
$8.44M 0.6%
160,300
+15,300
+11% +$926K
KG
55
Kestrel Group
KG
$69.4M
$8.44M 0.6%
217,527
-38,423
-15% -$1.72M
NOGN
56
DELISTED
Nogin, Inc. Common Stock
NOGN
$8M 0.57%
40,000
– –
LMACA
57
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$7.82M 0.55%
794,435
– –
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$7.6M 0.54%
136,192
-349,808
-72% -$20.7M
CRESY
59
Cresud
CRESY
$795M
$7.48M 0.53%
1,545,036
-79,123
-5% -$527K
CPAQ
60
DELISTED
Counter Press Acquisition Corporation Class A Ordinary Share
CPAQ
$7.42M 0.52%
+745,000
New +$7.43M
OHAA
61
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$7.38M 0.52%
750,000
– –
VMCA
62
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
$7.01M 0.49%
+700,000
New +$7.02M
SQZ
63
DELISTED
SQZ Biotechnologies Company
SQZ
$6.86M 0.48%
2,157,738
+58,923
+3% +$212K
EUCR
64
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$5.94M 0.42%
600,000
– –
ANGI icon
65
Angi Inc
ANGI
$229M
$5.73M 0.41%
125,200
– –
NUVB icon
66
Nuvation Bio
NUVB
$2.2B
$5.72M 0.4%
1,766,657
+486,757
+38% +$2.12M
ALNY icon
67
Alnylam Pharmaceuticals
ALNY
$27.5B
$5.69M 0.4%
39,000
-10,000
-20% -$1.42M
COF icon
68
Capital One
COF
$128B
$5.21M 0.37%
+50,000
New +$6.11M
ARGU
69
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$5M 0.35%
500,000
– –
PROK icon
70
ProKidney
PROK
$316M
$4.97M 0.35%
500,000
– –
TRAQ
71
DELISTED
Trine II Acquisition Corp.
TRAQ
$4.97M 0.35%
500,000
– –
NKGN
72
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$4.86M 0.34%
500,000
– –
GIW
73
DELISTED
GigInternational1, Inc. Common Stock
GIW
$4.82M 0.34%
480,000
– –
PNST
74
DELISTED
Pinstripes Holdings, Inc.
PNST
$4.48M 0.32%
450,000
+250,000
+125% +$2.49M
CCTS
75
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$4.48M 0.32%
450,000
– –
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, 683 Capital Management held 375 positions worth $1.42B, down 24% from $1.87B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

683 Capital Management withdrew a net $52.5M in Q2 2022, closing 103 positions and reducing 27 holdings. Its most notable exit was Herbalife, an estimated $43.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in General Motors worth $38.3M.

  • 683 Capital Management's largest Q2 2022 buy was General Motors: 1,205,400 shares worth $38.3M.
  • 683 Capital Management added most to Carvana in Q2 2022, an estimated $46.6M increase.
  • 683 Capital Management's biggest Q2 2022 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $20.7M.
  • 683 Capital Management fully exited Herbalife in Q2 2022, selling an estimated $43.7M.
  • 683 Capital Management's ten largest holdings make up 30% of its $1.42B portfolio in Q2 2022.
  • 683 Capital Management opened 15 new positions and closed 103 in Q2 2022.
  • 683 Capital Management's portfolio value fell 24% quarter-over-quarter to $1.42B.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.